GLT8D4 activators are a class of compounds that target the protein encoded by the GLT8D4 gene, which is presumed to be involved in cellular processes based on its homology to other members of its gene family. Proteins in this family often play roles in metabolism, including glycosyltransferase activities-enzymes that catalyze the transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. Activators of GLT8D4 would therefore be molecules that enhance the enzymatic activity of the protein, potentially influencing the efficiency of glycosylation processes within the cell. These activators could act by various mechanisms, such as by binding to the protein and inducing a conformational change that increases its catalytic activity, by stabilizing the protein-substrate complex, or by enhancing the protein's interaction with other cellular components essential for its function. Understanding the structure and function of GLT8D4, including the active site and substrate specificity, is essential for the rational design of such activators.
The discovery of GLT8D4 activators would involve a multifaceted approach, integrating computational modeling with experimental biochemistry. In silico methods would be used to simulate the molecular structure of GLT8D4 and to predict how small molecules might interact with the protein. These studies would help identify potential binding sites for activators and suggest chemical structures that could interact favorably with the protein. Following computational predictions, chemical synthesis would be employed to produce candidate molecules, which would then be tested in vitro to confirm their activity. Enzyme assays that measure the rate of glycosyltransferase reactions in the presence of potential activators would be a direct method for assessing their functional impact on GLT8D4. Furthermore, the use of techniques such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) could provide additional data on the binding affinity and thermodynamics of the interaction between GLT8D4 and the activators. These experimental strategies would not only validate the activity of the compounds but also offer insights into the molecular details of their mechanism of action. Through such investigations, GLT8D4 activators could be harnessed to further explore the biological role of this enzyme and its contribution to cellular glycosylation pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
May induce the unfolded protein response (UPR) by inhibiting N-linked glycosylation, potentially upregulating GLT8D4. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
An inhibitor of glycoprotein processing that might increase demand for glycosyltransferase activity, possibly inducing GLT8D4. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
Inhibits mannosidase I in the ER, leading to enhanced UPR, which could hypothetically increase the expression of GLT8D4. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
A glucosidase inhibitor that could disrupt normal glycosylation and potentially increase the expression of glycosyltransferases like GLT8D4. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Another glucosidase inhibitor that may cause cellular stress in the ER, potentially impacting the expression of GLT8D4. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMP-activated protein kinase, which can regulate metabolic stress responses and might influence GLT8D4 expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER-to-Golgi traffic, leading to a stress response that could hypothetically upregulate glycosyltransferases like GLT8D4. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $112.00 $459.00 | 8 | |
Produces reactive oxygen species (ROS) in certain cells, potentially affecting the expression of stress-responsive genes, including GLT8D4. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Known to induce heat shock responses and may also affect protein folding processes in the ER, possibly influencing GLT8D4 expression. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Inhibits dephosphorylation of eIF2α, leading to an enhanced UPR, which might upregulate GLT8D4 expression. | ||||||